Skip to main content
Premium Trial:

Request an Annual Quote

David Franz, Margaret Hamburg, Stephen Albert Johnson, Scott Lillibridge, C J Peters, Peter Ehrenheim, Anthony Martin

Premium

Invitrogen created an advisory board last week for its biodefense research unit. David Franz, the chief biological scientist at Midwest Research Institute in Frederick, Md; and director of the National Agricultural Biosecurity Center at Kansas State University was appointed chairman. Those appointed as directors of the advisory board were: Margaret Hamburg, the vice president of biological programs of the Washington, D.C.-based Nuclear Threat Initiative; Stephen Albert Johnson, director of the Center for Biomedical Inventions based in Dallas; Scott Lillibridge, director for the Center for Biosecurity and Public Health Preparedness, based in Houston; and C J Peters, the director of Biodefense at the University of Texas Medical Branch Center for Biodefense and Emerging Infectious Diseases, based in Galveston, Texas.


GE Healthcare Biosciences has named Peter Ehrenheim president of protein separations, a role he initially assumed for Amersham in 1999. Ehrenheim has served as vice president for North American manufacturing for Amersham Pharmacia Biotech. He holds an MSc in mechanical engineering from the Royal Institute of Technology in Stockholm, Sweden.


Anthony Martin has been appointed to the board of directors of Windsor, Conn.-based Protedyne. Martin previously served as chairman and CEO of Molecular Probes.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.